Hydromorphone

Dilaudid

Opioid Agonist

NADAC/unit $0.1665

Active Shortage Tier 1: 110.3% PA Req: 49.8% 8 Manufacturers 32 ANDAs

Hydromorphone relieves moderate to severe pain by acting on opioid receptors in the brain.

vs. brand Dilaudid: Generic saves up to 98% per unit

Covered Lives

Active Shortages

2017-11-03 Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released., Hikma Pharmaceuticals USA, Inc.

2017-11-01 Shortage reported, Teva Pharmaceuticals USA, Inc.

2017-11-01 Next release March 2026. Check wholesalers for inventory., Fresenius Kabi USA, LLC

2017-11-01 Next release Q2-2026. Check wholesalers for inventory., Fresenius Kabi USA, LLC

2017-11-01 Estimated recovery: TBD, Teva Pharmaceuticals USA, Inc.

Generic Manufacturers

ASCENT PHARMACEUTICALS INCAUROLIFE PHARMA LLCFRESENIUS KABI USA LLCHIKMA PHARMACEUTICALS USA INCHOSPIRA INCOSMOTICA PHARMACEUTICAL US LLCPADAGIS US LLCRHODES PHARMACEUTICALS LPRISING PHARMA HOLDINGS INCSPECGX LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Hydromorphone drfinder.aiFind doctors who prescribe Hydromorphone hipreplacement.aiLearn about post-surgical pain management rxnews.aiLatest news about Hydromorphone

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.